HealthTree Podcast for Multiple Myeloma brings you patient-led interviews of the world's top multiple myeloma researchers. Call in live at showtime to (347) 637-2631 ask questions and to learn about the latest innovation in simple terms patients can understand.
https://www.blogtalkradio.com/myelomacrowdradio
Gesamtlänge aller Episoden: 14 days 8 hours 1 minute
mPatient Myeloma Radio: Dr. Jonathan Licht, MD, Robert H. Lurie CCC
Join us as we talk with Dr. Jonathan Licht of the Robert H. Lurie Comprehensive Cancer Center and Northwestern University about high risk myeloma.
mPatient Myeloma: Dr. Aaron Rapoport, MD, University of Maryland Cancer Ce
Join us as we talk with Dr. Aaron Rapoport, MD of the University of Maryland Greenbaum Cancer Center about his vaccine approaches and T-cell research in myeloma
mPatient Myeloma: Dr. Aaron Rapoport, MD, University of Maryland Cancer Ce
Join us as we talk with Dr. Aaron Rapoport, MD of the University of Maryland Greenbaum Cancer Center about his vaccine approaches and T-cell research in myeloma
mPatient Myeloma Radio: Dr. Robert Orlowski, MD, PhD, MD Anderson
Join us as we talk with Dr. Robert Z. Orlowski, MD, PhD of MD Anderson Cancer about immunotherapies and the latest in his myeloma research.
mPatient Myeloma Radio: Dr. Robert Orlowski, MD, PhD, MD Anderson
Join us as we talk with Dr. Robert Z. Orlowski, MD, PhD of MD Anderson Cancer about immunotherapies and the latest in his myeloma research.
mPatient Radio: Dr. Leif Bergsagel, MD, Mayo Clinic Scottsdale
Join us as we talk with Dr. Leif Bergsagel about his research to subdivide myeloma by genetic type and apply different therapy approaches to these unique variat
mPatient Radio: Dr. Leif Bergsagel, MD, Mayo Clinic Scottsdale
Join us as we talk with Dr. Leif Bergsagel about his research to subdivide myeloma by genetic type and apply different therapy approaches to these unique variat
mPatient Radio: Dr. Jens Lohr, Dana Farber Cancer Institute and BROAD Institute
Learn why myeloma is so genetically complicated and the implications this has for personalized medicine in myeloma. Dr. Lohr, MD, PhD of the Dana Farber Cancer
mPatient Radio: Dr. Jens Lohr, Dana Farber Cancer Institute and BROAD Institute
Learn why myeloma is so genetically complicated and the implications this has for personalized medicine in myeloma. Dr. Lohr, MD, PhD of the Dana Farber Cancer
mPatient Radio: Dr. Phillip McCarthy, Roswell Park Cancer Institute
Listen as we talk with Dr. Phillip McCarthy of the Roswell Park Cancer Institute about his work in immunotherapy, transplantation and myeloma care.